EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Metagenomic next-generation sequencing of matched donor–recipient pairs reveals pathogen transmission dynamics and informs antimicrobial therapy in liver transplantation: a retrospective cohort study

Shuai Feng, Jinquan Liu, Xiaojing Zhang, Lianghao Zhang, Shengbao Zhao, Nannan Jiang, Jinzhen Cai, Yafeng Zheng, Wei Gai, Chuanshen Xu

Frontiers in Cellular and Infection Microbiology · 2026

DOI: 10.3389/fcimb.2026.1919428 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2026. Verfasst von Shuai Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Organ Transplantation Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Liver Transplantation, High-Throughput Nucleotide Sequencing, Metagenomics, Tissue Donors. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Post-transplant infections remain a leading cause of morbidity and mortality after liver transplantation (LT). Conventional microbiological culture has well-recognized limitations in sensitivity and pathogen spectrum coverage. Metagenomic next-generation sequencing (mNGS) has emerged as a promising diagnostic platform. However, its systematic evaluation across matched donor–recipient pairs, including characterization of possible donor-to-recipient pathogen transmission and its impact on antimicrobial stewardship, remains limited.

Methods

We retrospectively enrolled 45 consecutive LT donor–recipient pairs. Multiple sample types were collected from donors ( n = 124) and recipients ( n = 97) and subjected to both mNGS and conventional culture. Recipients were stratified into infection ( n = 29) and non-infection ( n = 16) groups. Pathogen detection rates, diagnostic performance metrics, donor-to-recipient transmission events, and mNGS-informed antimicrobial modifications were systematically analyzed.

Results

Post-transplant infection occurred in 64.4% of recipients, predominantly involving the pulmonary compartment (89.7%). mNGS achieved significantly higher overall positivity rates than culture in both donors (95.6% vs . 80.0%) and recipients (64.4% vs . 22.2%), with superior detection of fungi and exclusive identification of all viral pathogens. The pathogen-level concordance between methods was predominantly partial (75%–78%). At the patient level, mNGS demonstrated a sensitivity of 69.0% versus 31.0% for culture, while culture maintained higher specificity (93.8% vs . 43.8%). A diverse pathogen landscape was identified, including Pneumocystis jirovecii , rare molds, cytomegalovirus (CMV), and Epstein–Barr virus (EBV)—all exclusively detected by mNGS. A total of 11 possible donor-to-recipient transmission events involving six pathogens were identified across 11 pairs, and 54.5% of affected recipients developed clinical infections, with Klebsiella pneumoniae accounting for the majority of transmission events. mNGS results informed antimicrobial treatment modifications in 69.0% of infected recipients. In the univariate analysis, liver cancer showed an exploratory association with lower post-transplant infection risk (OR = 0.10, 95%CI = 0.02–0.46, p = 0.003).

Conclusions

This retrospective matched-pair study suggests that mNGS substantially expands pathogen detection beyond conventional culture, enabling the identification of clinically relevant possible donor-derived pathogen transmission and informing antimicrobial treatment modifications in the majority of infected recipients. These findings support mNGS as an adjunctive peri-transplant diagnostic tool pending prospective multicenter validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHigh-Throughput Nucleotide SequencingMetagenomicsTissue DonorsTransplant RecipientsAnti-Infective AgentsHumansRetrospective StudiesFemaleMaleMiddle AgedAdult

Stichwörter der Autor:innen

antimicrobial stewardshipdonor-derived infectionliver transplantationmetagenomic next-generation sequencingpost-transplant infection

Substanzen

Anti-Infective Agents

Autor:innen und Institutionen

  • Organ Transplantation Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • WillingMed Technology (Beijing) Co., Ltd, Beijing, China.
  • Department of Orthopaedics, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.

Zitieren

APA

Feng, S., Liu, J., Zhang, X., Zhang, L., Zhao, S., Jiang, N., Cai, J., Zheng, Y., Gai, W., & Xu, C. (2026). Metagenomic next-generation sequencing of matched donor–recipient pairs reveals pathogen transmission dynamics and informs antimicrobial therapy in liver transplantation: a retrospective cohort study. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2026.1919428

Vancouver

Feng S, Liu J, Zhang X, Zhang L, Zhao S, Jiang N, et al. Metagenomic next-generation sequencing of matched donor–recipient pairs reveals pathogen transmission dynamics and informs antimicrobial therapy in liver transplantation: a retrospective cohort study. Frontiers in Cellular and Infection Microbiology. 2026. doi:10.3389/fcimb.2026.1919428

BibTeX
@article{Feng2026,
  author = {Feng, Shuai and Liu, Jinquan and Zhang, Xiaojing and Zhang, Lianghao and Zhao, Shengbao and Jiang, Nannan and Cai, Jinzhen and Zheng, Yafeng and Gai, Wei and Xu, Chuanshen},
  title = {Metagenomic next-generation sequencing of matched donor–recipient pairs reveals pathogen transmission dynamics and informs antimicrobial therapy in liver transplantation: a retrospective cohort study},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2026},
  doi = {10.3389/fcimb.2026.1919428}
}
Kostenlos starten →